Travere Therapeutics Inc. buy klostergang
Start price
01.07.19
/
50%
€19.10
Target price
04.11.21
€33.37
Performance (%)
-35.06%
End price
17.06.21
€12.40
Summary
This prediction ended on 17.06.21 with a price of €12.40. Massive losses of -35.06% were the result for the BUY prediction by klostergang. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Travere Therapeutics Inc. | 11.047% | 11.047% | 117.045% | - |
| iShares Core DAX® | 4,64 % | 7,49 % | 6,99 % | 53,73 % |
| iShares Nasdaq 100 | 4,47 % | 16,80 % | 40,28 % | 104,33 % |
| iShares Nikkei 225® | 7,67 % | 16,86 % | 47,87 % | 73,79 % |
| iShares S&P 500 | 2,47 % | 9,90 % | 28,43 % | 72,58 % |
Comments by klostergang for this prediction
In the thread Travere Therapeutics Inc. diskutieren
Retrophin mit FDA-Zulassung zur Behandlung von Cystinurie und
fortgeschrittener pipeline: